Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    CBRNE

    BAA for Medical Countermeasures Following a Nuclear Attack

    By Global Biodefense StaffAugust 3, 2012
    Share
    Facebook LinkedIn Reddit Email

    The National Institute of Allergy and Infectious Diseases (NIAID) is soliciting proposals for development of products for treatment of radiation exposures resulting from nuclear and radiological attacks.

    Under a new Broad Agency Announcement (BAA), the institute is seeking organizations with the capabilities to advance the development of candidate medical countermeasures (MCMs) for gastrointestinal acute radiation syndrome (GI-ARS).

    NIAID anticipates that research and development studies supported by this BAA will advance candidate MCMs toward eventual FDA approval or licensure for GI-ARS. Offeror are expected to provide a Statement of Work describing the stage of the candidate and the work that needs to be performed to advance the MCM.

    It is anticipated that 2-4 contracts will be awarded for a 3-year period of performance beginning on or about July 15, 2013.

    The NIAID Division of Allergy, Immunology and Transplantation has oversight on this activity. The full BAA is estimated to be released on August 15, 2012. Further details are available under Solicitation Number: BAA-NIAID-DAIT-NIHAI2012147. The current proposal deadline is November 15, 2012.

    BAA Radiation
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleNIH, CDC Announce Small Business Innovation Research Opportunity
    Next Article Luminex Wins Biodetector Contract from DTRA

    Related Stories

    Jurata Thin Film and CastleVax Awarded Grant to Advance Thermostabilized COVID-19 Booster

    September 20, 2023

    SOREX Brings Top CBRNE Units to Dugway Proving Ground

    September 20, 2023

    Biomarkers for Detection of Exposure to Nitrogen Mustards

    September 20, 2023

    Mount Sinai to Lead Development of Pan-Coronavirus Vaccine Under New Federal Grant

    September 17, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.